ABVC BioPharma Plans to Expand Investment in U.S. for Production Facilities and Products for Unmet Medical Needs 05.03.2025 / 22:07 CET/CEST The issuer is solely responsible for the content of this ...

For cell therapy research and clinical applications, Sino Biological is devoted to manufacturing high-quality reagents. By applying a quality management system that sticks to GMP standards ...

This initiative addresses long-standing concerns over inconsistent certificate formats and verification challenges across ...

Specialized technical knowledge in process and analytical development in combination with GMP facilities are essential ... AAVs are needed to meet growing clinical and subsequent commercial ...

Health researchers working with DENT Neurologic Institute, Jamaica pharmaceutical company to increase global clinical ...

Scientists will work with DENT Neurologic Institute and a Jamaican pharma company to advance global clinical research.

Symbiosis’ completion of the FDA regulatory review is expected to increase the company’s commercial-scale sterile manufacturing capabilities.

announces today it has commenced preliminary work related to the Good Manufacturing Practice (GMP) manufacturing process for its PL-14 allergy blocker in preparation for its planned 2025 clinical ...

Q1 2025 Management View The company announced a strategic restructuring to focus on its LineaRx subsidiary, exiting the DNA Tagging and Security Products and Services segment. This move is expected to ...